SCHEMBL31437073

SCHEMBL31437073

CC(C)(C)OC(=O)NC1CCN(S(=O)(=O)c2cccc(C3CCN(CC4CCNCC4)CC3)c2)CC1

nearest known ligand 0.48

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 4/20 0.48
RORC P51449 1/20 0.44
SMYD3 Q9H7B4 1/20 0.42
CCR5 P51681 1/20 0.42
PKM P14618 3/20 0.42
KCNA3 P22001 1/20 0.42
NAMPT P43490 1/20 0.41
TSHR P16473 1/20 0.41
JAK2 O60674 2/20 0.41
JAK1 P23458 2/20 0.41
USP5 P45974 3/20 0.41
KMT2A Q03164 1/20 0.41
BRD4 O60885 2/20 0.40
DRD3 P35462 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24571646 1.00 DRD2 (0.48) DRD2RORCSMYD3CCR5PKM
SCHEMBL31437067 0.91 RORC (0.49) RORCPKMNAMPTTSHRUSP5
SCHEMBL24571241 0.91 RORC (0.49) RORCPKMNAMPTTSHRUSP5
SCHEMBL24571698 0.89 DRD2 (0.47) DRD2RORCSMYD3CCR5PKM
SCHEMBL27298536 0.86 USP5 (0.45) DRD2RORCSMYD3CCR5PKM
SCHEMBL29640961 0.85 F13A1 (0.45) DRD2RORCCCR5PKMTSHR
SCHEMBL27298520 0.85 F13A1 (0.45) DRD2RORCCCR5PKMTSHR
SCHEMBL24572248 0.81 DRD2 (0.42) DRD2RORCSMYD3CCR5PKM
SCHEMBL29640896 0.81 DRD2 (0.42) DRD2RORCSMYD3CCR5PKM
SCHEMBL29640893 0.81 DRD2 (0.42) DRD2RORCSMYD3CCR5PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120152967-A Bifunctional compounds containing 2, 5-substituted pyrimidine derivatives for degradation of cyclin-dependent kinase 2 via the ubiquitin proteasome pathway 霖康疗法公司 2025-06-13 CN disclosed
CN-119630644-A Bifunctional compounds containing pyrimidine derivatives for degradation of cyclin-dependent kinase 2 via the ubiquitin proteasome pathway 霖康疗法公司 2025-03-14 CN disclosed
CN-119630651-A Bifunctional compounds containing substituted pyrimidine derivatives for degradation of cyclin-dependent kinase 2 via the ubiquitin proteasome pathway 霖康疗法公司 2025-03-14 CN disclosed